Machine Learning

San Diego's Blacksmith Medicines will present promising data on its FEN1 inhibitor, a new drug targeting a notoriously difficult class of enzymes.

Following a $295M exploit, Solana DEX Drift Protocol gets a lifeline from Tether, plotting a relaunch that will reshape the ecosystem's stablecoin landscape.

The chipmaker is expanding beyond consumer electronics, launching a new IC family to power the next generation of high-precision industrial scanners and machine vision.

A new Army contract for TurbineOne's edge AI reveals a radical shift in military procurement, empowering soldiers to fast-track the tech they need.

As antitrust enforcement surges worldwide, Charles River Associates' strategic re-hire of M&A specialist Hitesh Makhija signals a new front in the talent wars.

A four-legged robot powered by physical AI is set to revolutionize heavy industry by tackling the welder shortage and bringing automation to the field.

GNC partners with MitoQ to launch supplements aimed at mitochondrial health, tapping into the booming anti-aging market. But does the science hold up?

A new partnership combines live biopsy analysis with agentic AI, seeking to predict immunotherapy response and solve why only 1 in 5 patients benefit.

A Boston biotech says its new AI platform moves beyond correlation to find the true biological causes of disease, promising a new era for medicine.

The first MVPD to adopt the solution, DIRECTV now offers advertisers faster, more accurate, and secure insights to connect ad spend to real-time outcomes.

From $1,300 DIY setups to $100K+ labs, a new guide offers a crucial roadmap for researchers navigating the complex, costly world of VR investment.

A new 'agentic' AI from Deepdub works alongside human teams, promising to scale global content localization without sacrificing creative control or quality.

De'Longhi's new PrimaDonna Aromatic uses AI to perfect your coffee, from espresso to cold brew, blending award-winning design with deep personalization.

A novel immunotherapy tames a potent but toxic cancer-fighting agent by locking it inside tumors, offering new hope for patients with resistant cancers.

A new study reveals disinformation cost the world $417 billion in 2024, shifting the threat from a political issue to a core economic and business risk.

As dating app fatigue grows and traditional matchmaking costs soar 26%, a new breed of affordable, human-led services is gaining traction with singles.

Quintara Biosciences launches AmpValue, a $4.99 overnight sequencing service set to disrupt biotech by making advanced, full-length data accessible to all.

With a new $20M investment, Sennos is set to disrupt ancient fermentation processes using AI, promising a new era of efficiency and control.

A new integration between Supio and Thomson Reuters Westlaw Advantage promises to eliminate research silos, merging AI case intelligence with legal research.

Perpetuals.com is licensing its powerful BayesShield AI to a German university, gaining a key foothold in the booming $83 billion online education market.